Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities



Rating:

Share or cite this content

Citations should be made in the following way:
O. Komissarova (Moscow, Russian Federation), R. Abdullaev (Moscow, Russian Federation), S. Aleshina (Moscow, Russian Federation). Adverse events in the treatment of patients with pulmonary tuberculosis combined with diabetes mellitus and without it.. 1028

Member's Comments

No comment yet.

Related content which might interest you: Diabetes mellitus as cause of treatment failure and relapses of pulmonary tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 311s Year: 2001 Treatment effectiveness among patients with newly detected pulmonary tuberculosis with diabetes mellitus comorbidity Source: Eur Respir J 2004; 24: Suppl. 48, 653s Year: 2004 Newly detected pulmonary tuberculosis in patients combined with diabetes mellitus and without it. Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019 Impact of diabetes mellitus on pulmonary tuberculosis clinical presentation and treatment outcomes Source: International Congress 2018 – Tuberculosis comorbidities Year: 2018 Prevention and mechanism of undesirable adverse reactions in patients with pulmonary tuberculosis with extensive drug-resistance (XDR) combined with type 2 diabetes Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019 Risks of diabetes mellitus and hyperglycaemic adverse events in patients with COPD taking inhaled corticosteroids Source: Annual Congress 2011 - Airways disease comorbidities and general aspects Year: 2011 Presentations and treatment response of pulmonary tuberculosis in type 2 diabetes mellitus Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012 Clinical features of pulmonary tuberculosis in patients with diabetes mellitus Source: Annual Congress 2012 - Tuberculosis: clinical findings III Year: 2012 Outcomes among patients with pulmonary TB with diabetes mellitus treated with anti-TB drugs of 1st line Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities Year: 2010 Risks of diabetes mellitus and hyperglycaemic adverse events in patients with asthma taking inhaled corticosteroids Source: Annual Congress 2011 - Asthma management and response Year: 2011 ?cute phase proteins in patients with pulmonary tuberculosis combined with diabetes mellitus. Source: International Congress 2017 – Human susceptibility to tuberculosis Year: 2017 Is there any characteristics difference between pulmonary tuberculosis patients with and without diabetes mellitus type 2? Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities Year: 2009 Impact of diabetes mellitus on clinical parameters and treatment outcomes of diagnosed pulmonary tuberculosis patients Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014 Safety profile of COPD medications in COPD patients with concomitant diabetes mellitus Source: International Congress 2017 – COPD management Year: 2017 Pulmonary microangiopathy as a possible complication in patients with diabetes mellitus Source: Eur Respir J 2004; 24: Suppl. 48, 222s Year: 2004 COPD prevalence and severity is associated to type 2 diabetes mellitus complications and lack of glycometabolic control Source: Annual Congress 2008 - COPD and comorbidities Year: 2008 Intensive chemotherapy of pulmonary tuberculosis in patients with diabetes mellitus Source: Eur Respir J 2004; 24: Suppl. 48, 648s Year: 2004 The coexisting pulmonary tuberculosis and diabetes mellitus Source: Eur Respir J 2006; 28: Suppl. 50, 26s Year: 2006 Role of BMI in the clinical course of COPD patients with type 2 diabetes mellitus Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 The evaluation of tuberculosis risk in diabetes mellitus patients in a high incidence of tuberculosis region Source: Annual Congress 2010 - Tuberculosis: metabolic insights Year: 2010